{
    "nctId": "NCT03429296",
    "briefTitle": "Autohypnosis and Cancerology",
    "officialTitle": "Prospective, Randomized Study Aiming to Assess the Benefit of Autohypnosis Learning in the Care of Patients Treated by Adjuvant Chemotherapy for Colorectal or Breast Cancer.",
    "overallStatus": "COMPLETED",
    "conditions": "Colorectal Cancer, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": ">20% increase of the EORTC QLQC30 score (annexe 1) at the third week after the last chemotherapy session in the auto-hypnosis arm compared to the standard care arm.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age superior or equal to 18 years old\n* Colorectal or breast cancer history, treated by surgery and that should undergo an adjuvant chemotherapy\n\n  * In the case of breast cancer, adjuvant chemotherapy must involve anthracyclines\n* ECOG performance score \\< 3\n* Patient must be affiliated or beneficiary of social security or any similar regime\n\nExclusion Criteria:\n\n* Patients already included in another interventional clinical research protocol\n* Patients unable to proceed to hypnosis treatment due to their speech limitations (poor comprehension and expression of french, deafness, mental illness)\n* Patients protected by French law from clinical inclusion ( pregnant, in labour, breastfeeding, legally protected, under judiciary or administrative liberty deprivation...)",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}